SHIFT AI Newsroom · GLOBAL
Tirzepatide Being Investigated for Endometrial Hyperplasia and Grade 1 Endometrial Cancer
A clinical trial is underway to study the use of tirzepatide, in combination with a progestin intrauterine device, for the treatment of endometrial hyperplasia and grade 1 endometrial cancer.
A clinical trial is underway to study the use of tirzepatide, in combination with a progestin intrauterine device, for the treatment of endometrial hyperplasia and grade 1 endometrial cancer. The trial is currently registered on ClinicalTrials.gov.
What this means in the UK
This trial may potentially lead to new treatment options for individuals with endometrial hyperplasia and grade 1 endometrial cancer in the UK, although it is still in the early stages of research.
Known facts
- A clinical trial is investigating the use of tirzepatide and a progestin intrauterine device for the treatment of endometrial hyperplasia and grade 1 endometrial cancer.